167 related articles for article (PubMed ID: 18089882)
1. Carcinoma erysipeloides from ovarian clear-cell carcinoma.
Lee HC; Chu CY; Hsiao CH
J Clin Oncol; 2007 Dec; 25(36):5828-30. PubMed ID: 18089882
[No Abstract] [Full Text] [Related]
2. [Chemotherapy for ovarian cancer--introduction].
Yamada H; Sugiyama T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():540-5. PubMed ID: 15535304
[No Abstract] [Full Text] [Related]
3. [A case of advanced clear cell carcinoma of the endometrium that responded remarkably to neoadjuvant chemotherapy of combination carboplatin plus weekly paclitaxel].
Takami M; Ohta Y; Nakayama Y; Fukai H; Matsumoto H; Takimoto T; Sakamoto H; Yamamoto T
Gan To Kagaku Ryoho; 2007 Mar; 34(3):457-60. PubMed ID: 17353643
[TBL] [Abstract][Full Text] [Related]
4. [Therapy for ovarian cancer--general review].
Ochiai K
Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
[No Abstract] [Full Text] [Related]
5. [Clinical characteristics and therapeutic variations in elderly patients with ovarian cancer].
Kihana T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():632-5. PubMed ID: 15535322
[No Abstract] [Full Text] [Related]
6. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
7. Re: "Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study".
Markman M
Gynecol Oncol; 2007 Apr; 105(1):279-80; author reply 280-1. PubMed ID: 17291570
[No Abstract] [Full Text] [Related]
8. Skin metastasis of ovarian cancer: a rare entity.
Arslan C; Dede DS; Dizdar O; Altundag K
J BUON; 2010; 15(2):398-9. PubMed ID: 20658746
[No Abstract] [Full Text] [Related]
9. Skin metastasis in ovarian carcinoma.
Yilmaz Z; Bese T; Demirkiran F; Ilvan S; Sanioglu C; Arvas M; Kosebay D
Int J Gynecol Cancer; 2006; 16 Suppl 1():414-8. PubMed ID: 16515636
[TBL] [Abstract][Full Text] [Related]
10. Bone metastasis as the presenting complaint in ovarian carcinoma.
Kingston R; Sparkes J; Leen E; Stafford-Johnson D; Keogh P
Acta Obstet Gynecol Scand; 2001 Jul; 80(7):669-70. PubMed ID: 11437731
[No Abstract] [Full Text] [Related]
11. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
[TBL] [Abstract][Full Text] [Related]
12. Ovarian clear cell carcinoma with choriocarcinomatous differentiation: report of a rare and aggressive tumor.
Hu YJ; Ip PP; Chan KK; Tam KF; Ngan HY
Int J Gynecol Pathol; 2010 Nov; 29(6):539-45. PubMed ID: 20881859
[TBL] [Abstract][Full Text] [Related]
13. Borderline mucinous tumour with mural nodule of signet ring adenocarcinoma.
Ong NC; Ostör AG
Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):561-2. PubMed ID: 12495115
[No Abstract] [Full Text] [Related]
14. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
[TBL] [Abstract][Full Text] [Related]
15. Primary clear cell carcinoma of a paratubal cyst: a case report with literature review.
Hwang JH; Song SH; Shin BK; Lee JK; Lee NW; Lee KW
Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):284-5. PubMed ID: 21631454
[No Abstract] [Full Text] [Related]
16. Perforating cutaneous metastasis from an ovarian adenocarcinoma.
Abbas O; Salem Z; Haddad F; Kibbi AG
J Cutan Pathol; 2010 Sep; 37(9):e53-6. PubMed ID: 19615029
[TBL] [Abstract][Full Text] [Related]
17. Early-stage ovarian cancer management: still a challenge.
González Martín A
Clin Transl Oncol; 2011 Feb; 13(2):67-8. PubMed ID: 21324791
[No Abstract] [Full Text] [Related]
18. Pulmonary tumor thrombotic microangiopathy caused by an ovarian cancer expressing tissue factor and vascular endothelial growth factor.
Chinen K; Fujino T; Horita A; Sakamoto A; Fujioka Y
Pathol Res Pract; 2009; 205(1):63-8. PubMed ID: 18835104
[TBL] [Abstract][Full Text] [Related]
19. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
[TBL] [Abstract][Full Text] [Related]
20. "Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma" Safra T, et al (Gynecol Oncol 2009; 114:215-218).
Markman M
Gynecol Oncol; 2009 Dec; 115(3):514; author reply 514-5. PubMed ID: 19766296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
